CUREMARK

WIPO WIPO 2021

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke CUREMARK wurde als Wortmarke am 28.04.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 09. Januar 2023

Markenform Wortmarke
Aktenzeichen 1600873
Länder Australien Brasilien Kanada Schweiz Kolumbien Ägypten Europäische Gemeinschaft Großbritannien Israel Indien Japan Südkorea Liechtenstein Mexiko Neuseeland Russland Singapur Thailand Türkei
Basismarke US Nr. 90322325, 16. November 2020
Anmeldedatum 28. April 2021
Ablaufdatum 28. April 2031

Markeninhaber

Suite 528 South
800 Westchester Avenue
US

Markenvertreter

30 S. 17th Street Philadelphia PA 19103 US

Waren und Dienstleistungen

05 Pharmaceutical preparations and substances for the diagnosis, treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of influenza, coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, autism, autism spectrum disorder, attention deficit hyperactivity disorder and williams syndrome; antibacterial, antiviral and antifungal preparations for skin and wound healing; disinfectants and antiseptics; antimicrobial cleansers for sanitation purposes; medical assays for testing of bodily fluids and tissues for testing of enzymes in humans; biological preparations for medical testing; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing; diagnostic biomarker reagents for medical testing; all the foregoing for the diagnosis and treatment of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders
42 Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical research; development of pharmaceuticals and medical devices for others; providing temporary use of non-downloadable computer software that allows users to make determinations regarding neurological diseases, specifically baseline staging, data gathering and monitoring of early, middle and late stage neurological diseases; design and development of medical assays for others; clinical research and development of treatments for viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; clinical research and development of treatments for the treatment and prevention of influenza, coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, autism, autism spectrum disorder, attention deficit hyperactivity disorder and williams syndrome; clinical research and development of treatments for antibacterial, antiviral, and antifungal preparations for skin and wound healing; clinical research and development of disinfectants, antiseptics and antimicrobial cleansers for sanitation purposes; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body
44 Medical testing for diagnostic and treatment purposes; medical consultations; medical testing for diagnostic treatment purposes in the fields of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; medical testing for diagnostic treatment and prevention of influenza, coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, autism, autism spectrum disorder, attention deficit hyperactivity disorder and williams syndrome; medical diagnostic testing, monitoring and reporting services; performing diagnosis of diseases
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
05. Januar 2023 2023/1 Gaz TH Ablehnung
01. Dezember 2022 2022/48 Gaz KR Ablehnung
19. Oktober 2022 2022/42 Gaz CA Ablehnung
02. August 2022 2022/33 Gaz IL RAW: Rule 18ter(2)(i) GP following a provisional refusal
13. Juli 2022 2022/28 Gaz BR Ablehnung
07. Juli 2022 2022/27 Gaz MX Ablehnung
01. Juli 2022 2022/27 Gaz LI Ablehnung
28. Juni 2022 2022/27 Gaz EG Ablehnung
02. Juni 2022 2022/22 Gaz CH Ablehnung
21. April 2022 2022/16 Gaz JP Ablehnung
21. April 2022 2022/16 Gaz CO Ablehnung
28. Februar 2022 2022/9 Gaz TR Ablehnung
17. Februar 2022 2022/7 Gaz GB Ablehnung
07. Januar 2022 2022/1 Gaz SG Ablehnung
06. Januar 2022 2022/1 Gaz NZ Ablehnung
02. Dezember 2021 2021/50 Gaz IL Ablehnung
25. November 2021 2021/47 Gaz EM Ablehnung
11. Oktober 2021 2021/41 Gaz RU Ablehnung
28. September 2021 2021/39 Gaz AU Ablehnung
20. Juli 2021 2021/30 Gaz IN Ablehnung
28. April 2021 2021/25 Gaz US Eintragung

ID: 141600873